Responses
Ovarian Cancer
The Impact of Number of Cycles of Neoadjuvant Chemotherapy on Survival of Patients Undergoing Interval Debulking Surgery for Stage IIIC–IV Unresectable Ovarian Cancer: Results From a Multi-Institutional Study
Compose a Response to This Article
Other responses
No responses have been published for this article.